Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,046 | 111,471 | 215,507 | 244,979 | 238,605 |
| TOTAL | $51,232 | $116,406 | $220,431 | $247,292 | $240,681 |
| Non-Current Assets | |||||
| PPE Net | 678 | 1,603 | 2,728 | 3,676 | 4,102 |
| Other Non-Current Assets | 512 | 1,649 | 2,577 | 3,454 | 154 |
| TOTAL | $1,190 | $3,252 | $5,305 | $7,130 | $4,256 |
| Total Assets | $52,422 | $119,658 | $225,736 | $254,422 | $244,937 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,704 | 26,720 | 21,610 | 18,424 | 12,068 |
| TOTAL | $14,540 | $28,344 | $23,131 | $19,813 | $32,261 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 682 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 20,193 |
| Other Non-Current Liabilities | 23,617 | 20,642 | 22,266 | 23,788 | 5 |
| TOTAL | $23,617 | $20,642 | $22,266 | $23,788 | $2,702 |
| Total Liabilities | $38,157 | $48,986 | $45,397 | $43,601 | $34,963 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,401 | 48,097 | 47,607 | 37,321 | N/A |
| Common Shares | 6 | 5 | 5 | 4 | 3 |
| Retained earnings | -486,039 | -416,263 | -292,801 | -186,319 | -90,917 |
| TOTAL | $14,265 | $70,672 | $180,339 | $210,821 | $209,974 |
| Total Liabilities And Equity | $52,422 | $119,658 | $225,736 | $254,422 | $244,937 |